Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II peripheral blood stem cell harvest using low-dose cyclophosphamide plus G-CSF for POEMS syndrome
jRCTs031180421Phase 2Completed
- Start
- Aug 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of cyclophosphamide in osteosclerotic myeloma (POEMS) and multiple myeloma (MM). Primary endpoint: Success rate of PBSC harvest. Started Aug 2016; status: completed.
02
Drugs
cyclophosphamide
03
Conditions
osteosclerotic myeloma (POEMS)multiple myeloma (MM)
Beyond the preview
Go deeper on jRCTs031180421.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031180421.